[Discussion Points] NCDs-related Cross-project “Lessons and Challenges Drawn from NCDs Responses in Local Governments and Future Visions” (June 17, 2024)
date : 8/19/2024
Tags: Cardiovascular Diseases, Kidney Disease, NCDs, Obesity
The English version of the report has been published. (August 19, 2024)
Health and Global Policy Institute (HGPI) formulated “Lessons and Challenges Drawn from NCDs Responses in Local Governments and Future Visions.”
HGPI held the meeting ”The 1st NCDs Meeting in Kyushu” on December 7th 2023 and “The 2nd Meeting on Non-Communicable Diseases (NCDs) in Hokkaido and Tohoku” on March 15th 2024.
This meeting aimed at enhancing the understanding of NCDs, which require intervention and management across sectors in the community and workplaces. The meeting also discussed how NCDs measures should be tailored to local conditions and characteristics, as well as to promote the horizontal development of policies across the community.
HGPI has crystallized the discussion points related to topics that were discussed by participants on these meeting as well as their future prospects.
Discussion point 1: Cardio-renal-metabolic conditions, obesity, and related risk factors can be viewed as interrelated conditions. Rather than advancing regional control measures that target individual conditions, it will be necessary to establish systems using a more integrated approach that spans prevention and treatment to rehabilitation.
Discussion point 2: To improve uptake for routine and specific medical checkups, adopt methods of recommending checkups and providing explanations that reflect the circumstances of the people receiving them.
Discussion point 3: To encourage people whose checkup results require follow-up or more detailed testing to visit health institutions for secondary examinations, it will be important to have conversations that are in line with their lifestyles as well as to eliminate obstacles to medical examinations.
Discussion point 4: To ensure follow-up examinations provided after medical checkups are of high quality, and to enable family doctors to be able to provide referrals to and collaborate with specialists at the right times, it will be necessary to standardize care, to disseminate diagnostic and referral criteria, and to establish networks that facilitate healthcare collaboration.
Discussion point 5: The uneven geographical distribution of specialists results in cases where the windows for early detection are missed, so access to specialists should be improved through healthcare digital transformation (DX).
Discussion point 6: Measures for lifestyle disease control should include measures to reinforce the capacities of prefectural and municipal officials and to promote collaboration among them.
Discussion point 7: In each municipality, public health centers play key roles in cross-cutting collaboration that spans multiple diseases, and their functions should be reinforced.
Discussion point 8: Ensuring smooth collaboration among public health centers, prefectural governments, and municipal governments will be important. Doing so will require establishing systems for collaboration that are centered on public health centers and that involve stakeholders in the region.
Discussion point 9: In addition to measures limited to the public sector, there are examples in which cooperating with the private sector enhanced measures for lifestyle diseases. Cooperation among industry, Government, and academia is important.
Discussion point 10: Expectations are high for a population approach taken through stronger collaboration between community health and occupational health.
Discussion point 11: Obesity control is becoming more important for preventing the exacerbation of other diseases, but obesity measures at the municipal level are generally limited to metabolic syndrome. Obesity awareness must be expanded.
Discussion point 12: A system must be established that allows people to access the right treatment and support that is suited to the policy stage for each disease. Systems for intra-regional collaboration that are designed in a manner that they cut across diseases should also be established.
Discussion point 13: Lifestyle disease control requires collaboration that involves various stakeholders, that encompasses a life course perspective, and that takes aspects related to socioeconomics and welfare into account.
For details, please see the PDF linked below.
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)
-
2026-06-15
[Registration Open] (Hybrid Format) Multidisciplinary Symposium for Cardiology, Nephrology, and Metabolic Medicine “Future Actions for Making Full Use of the Health Checkup System: Connecting Checkups to Treatment From the Perspective of Data Linkage” (July 6, 2026)



